Extramammary Paget disease
MONDO:0008177A malignant neoplasm in which there is infiltration of the skin by neoplastic large cells with abundant pale cytoplasm and large nuclei with prominent nucleoli (Paget cells). It may affect the anus, penis, scrotum, and vulva.
Also known as: Extramammary Paget's disease, Paget disease Extramammary, Paget's disease of skin, Paget's disease of the skin, Paget's skin disease, extramammary Paget disease, EMPD, Paget disease, EXTRAMAMMARY
2754 clinical trials for this condition and its sub-types, 7 tagged with Extramammary Paget disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Extramammary Paget disease
-
Vulval Paget disease 2 trials
-
Anal Paget disease 1 trial
2 sub-types
- Anal canal Paget disease 1 trial
- Perianal skin Paget disease 1 trial
-
Paget disease of the penis 0 trials
-
Cancer-Fighting virus teams up with immunotherapy to tackle rare skin tumors
Disease control OngoingThis phase II trial is testing whether a combination of talimogene laherparepvec (a modified herpes virus that infects and kills cancer cells) and nivolumab (an immunotherapy drug) can shrink tumors in people with rare skin cancers or lymphomas that haven't responded to standard …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC